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Abstract
Recently the probabilistic index (PI), which is defined as the probability P{Y ≤ Y ′} with Y
and Y ′ independent random variables, acquired an increase of interest in Biostatistics. The PI
is accepted as an informative and intuitive index for quantifying treatment effects, particularly
when the treatment does not only act on the mean response. In a clinical trial for example,
the effect of increased dosage of a drug on a response can affect the mean, dispersion and
even the tails of the density. The PI summarizes the effect on the shape of the distribution into
a simple effect measure. See for example, [1, 2, 3]. Most of these methods however, rely on
distributional assumptions and they are limited to comparing two groups while correcting for
additional covariates. We propose a much more general model for the PI,
P{Y ≤ Y ′|X,X ′} = m(X,X ′;β),
where (Y,X) and (Y ′, X ′) are independent and identically distributed random vectors and m
defines the relation between the probabilistic index and the predictors. This general represen-
tation makes the model applicable for a variety of designs. For example, if Y denotes the blood
pressure, X the dosage of a drug and the model P{Y ≤ Y ′} = expit {β(X ′ −X)} is consid-
ered, then expit{β} gives the probability that the blood pressure increases when the dosage
is increased by one unit. Hence the model allows for a meaningful effect quantification of a
continuous predictor on the response distribution, without making any restrictive distributional
assumptions. The model can easily be extended to multiple predictors. It is shown that the
framework naturally give rise to some traditional rank tests such as the Wilcoxon-Rank-Sum,
Kruskal-Wallis and Friedman-Rank test and it allows extending these tests to more complicated
designs. Asymptotic normality of the estimators and consistency of the covariance matrix es-
timator are established through semiparametric theory. The model is extensively illustrated on
examples and the estimation theory is validated in a simulation study.
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